BFLY vs IRMD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Butterfly Network (BFLY) shows a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a definitive bankruptcy risk assessment. Despite deeply negative profitability metrics—including a -90.31% profit margin and negative ROE/ROA—the company maintains strong liquidity (Current Ratio: 4.80) and a low Debt/Equity ratio of 0.10. Revenue growth is modest at 4.50% YoY, but earnings surprises have been consistently positive in recent quarters, suggesting operational improvements. However, aggressive insider selling worth $21.71M over the past six months contradicts the 'strong_buy' analyst consensus and raises concerns about insider confidence.
IRMD presents a dichotomy between exceptional operational performance and extreme valuation premiums. While the Piotroski F-Score of 4/9 indicates stable financial health and the company boasts an impressive 76.75% gross margin and a consistent 25-quarter earnings beat record, the stock is trading significantly above its Graham Number ($17.07) and Intrinsic Value ($51.62). The strong fundamental growth is currently offset by bearish insider activity from the CEO and a completely bearish technical trend (0/100).
Compare Another Pair
Related Comparisons
BFLY vs IRMD: Head-to-Head Comparison
This page compares Butterfly Network, Inc. (BFLY) and IRADIMED CORPORATION (IRMD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.